2020
DOI: 10.1016/j.jri.2019.102623
|View full text |Cite
|
Sign up to set email alerts
|

Associations between maternal inflammation during pregnancy and infant birth outcomes in the Seychelles Child Development Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 37 publications
0
12
1
Order By: Relevance
“…Some studies have reported, contrary to our finding, that maternal serum CRP and MCP-1 concentrations are negatively correlated to birthweight. Thus, CRP at 28 weeks' gestation in healthy pregnant women, as well as maternal MCP-1 at third trimester (32-34 weeks), were associated with SGA births [19,20]. The discrepancy between our finding and others might be related to gestational age at sampling.…”
Section: Discussioncontrasting
confidence: 86%
See 1 more Smart Citation
“…Some studies have reported, contrary to our finding, that maternal serum CRP and MCP-1 concentrations are negatively correlated to birthweight. Thus, CRP at 28 weeks' gestation in healthy pregnant women, as well as maternal MCP-1 at third trimester (32-34 weeks), were associated with SGA births [19,20]. The discrepancy between our finding and others might be related to gestational age at sampling.…”
Section: Discussioncontrasting
confidence: 86%
“…MCP-1 increases during normal pregnancy and even more during labor, suggesting that MCP-1 modulates the immune system as pregnancy advances. Several studies have reported that maternal serum CRP and MCP-1 concentrations are negatively correlated to birthweight [19,20].…”
Section: Introductionmentioning
confidence: 99%
“…Understanding the association of maternal inflammatory responses during pregnancy with birth and infant outcomes could potentially help identify interventions (eg, anti-inflammatory agents) that could reduce adverse birth outcomes and infant growth deficits. 6 …”
Section: Introductionmentioning
confidence: 99%
“…Understanding the association of maternal inflammatory responses during pregnancy with birth and infant outcomes could potentially help identify interventions (eg, antiinflammatory agents) that could reduce adverse birth outcomes and infant growth deficits. 6 To address these gaps in research, we measured inflammatory markers, informing on aspects of general inflammation and acute phase response, inflammasome activation, gut integrity, monocyte activation, and T H responses in pregnant women from a cohort study in India. We then assessed the association of these markers with adverse birth outcomes (PTB and LBW) and infant growth (length-for-age z score [LAZ], weight-for-age z score [WAZ], and weight-for-length z score [WLZ]).…”
Section: Introductionmentioning
confidence: 99%
“…The highest levels of hsCRP are found in the 3 rd trimester of gestation in severe pre-eclampsia pregnancies compared to control and mild pre-eclampsia 8 . Moreover, negative results for hemolysis, HELLP syndrome (Hemolysis, High Liver Enzymes, Low Platelet) and intrauterine growth inhibition were higher in the group with high hsCRP levels [9][10] . Preeclampsia is a well-known risk factor for poor fetal growth and prematurity 11 .…”
Section: Introductionmentioning
confidence: 95%